Plummer A L
Postgrad Med. 1978 Apr;63(4):36-41, 44-6, 48. doi: 10.1080/00325481.1978.11714802.
Many patients with pulmonary disease may have significant airflow obstruction. Bronchodilatation is an important aspect of treatment and can be achieved with beta-adrenergic agonists, methylxanthine derivatives, and anticholinergic agents. These can be used singly or in combination, depending on the severity of obstruction.
许多肺部疾病患者可能存在明显的气流阻塞。支气管扩张是治疗的一个重要方面,可通过β-肾上腺素能激动剂、甲基黄嘌呤衍生物和抗胆碱能药物实现。这些药物可单独使用或联合使用,具体取决于阻塞的严重程度。